New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – Rasna Therapeutics Inc. (0001582249) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – Rasna Therapeutics Inc. (0001582249) (Filer)
Filed: 2017-03-14 AccNo: 0001144204-17-014532 Size: 26 KB

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Filing Date: 2017-03-14T16:51:55-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1582249/000114420417014532/0001144204-17-014532-index.htm